Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational Study

NCT07054229 · clinicaltrials.gov ↗

RECRUITING

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Microwave Ablation
Contrast-enhanced Ultrasound
Genetic and Molecular Diagnostics
Papillary Thyroid Microcarcinoma

Interventions

DRUG: Contrast enhanced Ultrasound
GENETIC: 88-gene panel for thyroid cancer

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University